Abbott Laboratories
A$120.25
AUD
Last updated on --.
24h volume10.81M
24h highest121.64 AUD
24h lowest119.00 AUD
24h Price movement-0.95%
ABT recent prices
24 Hours
-0.95%-A$1.149
30 days
-8.43%-A$11.08
60 days
-15.64%-A$22.32
90 days
-26.13%-A$42.59
Key data
Previous close121.40 AUD
Market cap215.63B AUD
Volume10.81M
P/E ratio24.530000
Dividend yield (TTM)0.03%
Dividend amount0.88244 AUD
Next ex-dividend date15 Apr 2026
Next payment date15 May 2026
EPS diluted (TTM)5.0425 AUD
Net income (FY)8.79B AUD
Revenue (FY)63.22B AUD
Last report date29 Apr 2026
About Abbott Laboratories
HeadquartersABBOTT PARK
Employees (FY)115.00K
Revenue per employee (FY)549.73K AUD
Net income per employee (FY)76.44K AUD
Listed onNew York Stock Exchange
ABT conversion tables
 |  |
|---|---|
| 0.5 ABT | 60.12 AUD |
| 1 ABT | 120.25 AUD |
| 5 ABT | 601.25 AUD |
| 10 ABT | 1,202.5 AUD |
| |
|---|---|
| 0.5 AUD | 0.004158 ABT |
| 1 AUD | 0.008316 ABT |
| 5 AUD | 0.04158 ABT |
| 10 AUD | 0.08316 ABT |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
ABT is trading at A$120.25, -0.95% over the last 24 hours. Track live moves on the price chart at the top of this page.
The ABT stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. ABT is currently trading at A$120.25, -0.95% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on ABT price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. ABT's P/E ratio is currently 24.530000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from ABT; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against ABT's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Abbott Laboratories's market cap is currently 215.63B AUD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume10.81M
24h highest121.64 AUD
24h lowest119.00 AUD
24h Price movement-0.95%
Start trade with ABT Perpetual
Sign up to trade